Paul Gitman - Net Worth and Insider Trading

Paul Gitman Net Worth

The estimated net worth of Paul Gitman is at least $1 Million dollars as of 2025-06-28. Paul Gitman is the Director of BioSpecifics Technologies Corp and owns about 15,000 shares of BioSpecifics Technologies Corp (BSTC) stock worth over $1 Million. Details can be seen in Paul Gitman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul Gitman has not made any transactions after 2019-05-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Paul Gitman

To

Paul Gitman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Paul Gitman owns 1 companies in total, including BioSpecifics Technologies Corp (BSTC) .

Click here to see the complete history of Paul Gitman’s form 4 insider trades.

Insider Ownership Summary of Paul Gitman

Ticker Company Transaction Date Type of Owner
BSTC BioSpecifics Technologies Corp 2020-07-15 director

Paul Gitman Latest Holdings Summary

Paul Gitman currently owns a total of 1 stock. Paul Gitman owns 15,000 shares of BioSpecifics Technologies Corp (BSTC) as of May 15, 2019, with a value of $1 Million.

Latest Holdings of Paul Gitman

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BSTC BioSpecifics Technologies Corp 2019-05-15 15,000 88.53 1,327,950

Holding Weightings of Paul Gitman


Paul Gitman Form 4 Trading Tracker

According to the SEC Form 4 filings, Paul Gitman has made a total of 0 transactions in BioSpecifics Technologies Corp (BSTC) over the past 5 years. The most-recent trade in BioSpecifics Technologies Corp is the sale of 5,000 shares on May 15, 2019, which brought Paul Gitman around $329,150.

Insider Trading History of Paul Gitman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Paul Gitman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Paul Gitman Ownership Network

Ownership Network List of Paul Gitman

No Data

Ownership Network Relation of Paul Gitman

Insider Network Chart


Paul Gitman Owned Company Details

What does BioSpecifics Technologies Corp do?

Who are the key executives at BioSpecifics Technologies Corp?

Paul Gitman is the director of BioSpecifics Technologies Corp. Other key executives at BioSpecifics Technologies Corp include director & 10 percent owner Toby Wegman , director & Chief Executive Officer Joseph Truitt , and Chief Financial Officer Patrick Hutchison .

BioSpecifics Technologies Corp (BSTC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of BioSpecifics Technologies Corp (BSTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioSpecifics Technologies Corp (BSTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

BioSpecifics Technologies Corp (BSTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

BioSpecifics Technologies Corp Insider Transactions

No Available Data

Paul Gitman Mailing Address

Above is the net worth, insider trading, and ownership report for Paul Gitman. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Paul Gitman's mailing address is: 167 Executive Drive Manhasset Hills Ny 11040.